Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 09, 2023
Vetter has been granted a permanent Manufacturer’s Authorization for its clinical development facility located in Rankweil, Austria. This site has been in operation for nearly two years, and the Austrian Agency for Health and Food Safety (AGES), the ...
read more
Bionova Scientific announced it has licensed ATUM's proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.
read more
CMC ICOS Biologics and Trellis Bioscience have entered into a manufacturing agreement for the process development and production of two of Trellis’ monoclonal antibodies.
read more
Codexis and Porton Pharma announce a collaboration to deploy Codexis’ biocatalyst technology within Porton’s global custom intermediate and API development and manufacturing business.
read more
Friday, September 24, 2021
At Pfizer CentreOne we aspire to be the CDMO partner of choice. Over the last several years our team has been working to expand our development services offerings so we can truly be an end-to-end CDMO, from development through to commercial ...
read more
Tuesday, January 25, 2022
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, GMP vector production and analytical testing services, has appointed Laura Jacanin as Senior Director of ...
read more
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that the Life Science business has entered a collaboration with Agilent Technologies to advance Process ...
read more
Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a provider of specialty diagnostics, from a shareholder group led by European private equity firm Nordic ...
read more
Catalent announced Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca PLC at Catalent’s manufacturing facility in Anagni, Italy.
read more
Marken announced the launch of their Direct to Patient (DTP) White Book Industry Guide.
read more
Malvern Panalytical and Concept Life Sciences have jointly launched Amplify Analytics - a new range of highly flexible services designed to help pharmaceutical companies rapidly identify those drug candidates that meet bioavailability and ...
read more
GNS announced its rebranding as Aitia (pronounced "ay-tee-ah"). Aitia, derived from the Greek word for causality, will focus on further leveraging its Gemini Digital Twins to discover the next generation of breakthrough drugs to improve outcomes for ...
read more
Thursday, November 16, 2017
Crown Bioscience has held an extraordinary general meeting and announced results of stockholder elections for the company’s 2017 Board of Directors.
read more
Onco360 has been selected to participate in the limited distribution network of Braftovi and Mektovi for the treatment of patients with unresectable or metastatic melanoma.
read more
Tuesday, October 02, 2018
PCI Pharma Services has announced the completion of its acquisition of Sherpa Clinical Packaging.
read more